<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rdf.xsl"?>
<rdf:RDF  xmlns="http://purl.org/rss/1.0/"
				  xmlns:dc="http://purl.org/dc/elements/1.1/
					xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
					
<channel rdf:about="http://livepress.com">
          <title>Endometrial Cancer - livepress.com</title>
      <link>http://Endometrial Cancer.livepress.com</link>
      <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
  <dc:publisher>livepress.com</dc:publisher>
  <dc:creator>livepress.com</dc:creator>
  <dc:rights>Copyright &#169; 2006 livepress.com</dc:rights>
  <sy:updatePeriod>hourly</sy:updatePeriod>
  <sy:updateFrequency>2</sy:updateFrequency>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://livepress.com" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://livepress.com/go/?114602">
  		<title><![CDATA[Insulin resistance linked to endometrial cancer 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?114602</link>
  		  		<dc:description><![CDATA[Reuters - Resistance to the effects of 
the blood-sugar regulating hormone insulin could boost a 
woman's risk of  endometrial cancer , a new study suggests.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?40760">
  		<title><![CDATA[Study Confirms Tamoxifen Raises Endometrial Cancer Risk 
    (HealthDay)
]]></title>
	  	<link>http://livepress.com/go/?40760</link>
  		  		<dc:description><![CDATA[HealthDay - WEDNESDAY, March 2 (HealthDay News) -- Doctors often prescribe the drug tamoxifen to  breast cancer  patients over the long term, to help reduce the chances of cancer recurrence.]]></dc:description>
  				</item>
</rdf:RDF>